Sumayang, Nolasco L.

HRN: 24-37-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/10/2024
01/16/2024
IV
1.5gm
Q6
Cellulitis Left Leg
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: